Mark Ragosa
CHIEF FINANCIAL OFFICER · 2 filings · Latest: Apr 7, 2026
Kiniksa Pharmaceuticals International, plc
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
KNSA | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 7, 2026 | Tax Withholding | $48.94 | 1,303 | $63.8K | 16,154 | |
KNSA | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 7, 2026 | Option Exercise | — | 2,694 | — | 17,457 | |
KNSA | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 1, 2026 | Tax Withholding | $48.13 | 2,510 | $120.8K | 14,763 | |
KNSA | Mark Ragosa | CHIEF FINANCIAL OFFICER | Apr 1, 2026 | Option Exercise | — | 5,187 | — | 17,273 |